- Home
- LFVN vs INO Comparison
LFVN vs INO Comparison
Compare LFVN & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFVN
- INO
- Stock Information
- Founded
- LFVN N/A
- INO 1979
- Country
- LFVN United States
- INO United States
- Employees
- LFVN N/A
- INO N/A
- Industry
- LFVN Biotechnology: Pharmaceutical Preparations
- INO Medical/Dental Instruments
- Sector
- LFVN Health Care
- INO Health Care
- Exchange
- LFVN Nasdaq
- INO Nasdaq
- Market Cap
- LFVN 145.2M
- INO 136.6M
- IPO Year
- LFVN N/A
- INO 1998
- Fundamental
- Price
- LFVN $6.56
- INO $1.79
- Analyst Decision
- LFVN Strong Buy
- INO Buy
- Analyst Count
- LFVN 2
- INO 5
- Target Price
- LFVN $30.50
- INO $9.00
- AVG Volume (30 Days)
- LFVN 193.5K
- INO 1.4M
- Earning Date
- LFVN 11-04-2025
- INO 11-10-2025
- Dividend Yield
- LFVN 2.72%
- INO N/A
- EPS Growth
- LFVN 143.91
- INO N/A
- EPS
- LFVN 0.78
- INO N/A
- Revenue
- LFVN $228,877,000.00
- INO $182,337.00
- Revenue This Year
- LFVN $6.93
- INO N/A
- Revenue Next Year
- LFVN $1.43
- INO $14,751.49
- P/E Ratio
- LFVN $8.49
- INO N/A
- Revenue Growth
- LFVN 16.77
- INO N/A
- 52 Week Low
- LFVN $5.98
- INO $1.30
- 52 Week High
- LFVN $27.38
- INO $4.61
- Technical
- Relative Strength Index (RSI)
- LFVN 34.81
- INO 34.87
- Support Level
- LFVN $5.98
- INO $1.72
- Resistance Level
- LFVN $7.47
- INO $2.11
- Average True Range (ATR)
- LFVN 0.49
- INO 0.13
- MACD
- LFVN 0.05
- INO -0.04
- Stochastic Oscillator
- LFVN 36.84
- INO 11.11
About LFVN Lifevantage Corporation (Delaware)
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.